Procter & Gamble (NYSE:PG) Announces FY 2027 Earnings Guidance

Procter & Gamble (NYSE:PG) updated its FY 2027 earnings guidance on Friday. The company provided earnings per share guidance of 6.890-7.110 for the period, compared to the consensus EPS estimate of 6.980. The company issued revenue guidance of $86.0 billion-$87.7 billion, compared to the consensus revenue estimate of $88.8 billion.

Analyst Upgrades and Downgrades

PG has been the topic of several research reports. BMO Capital Markets raised their price objective on Procter & Gamble from $169.00 to $170.00 and gave the stock an “outperform” rating in a report on Monday, June 29th. Morgan Stanley boosted their target price on Procter & Gamble from $166.00 to $185.00 and gave the company an “overweight” rating in a report on Friday. Jefferies Financial Group upped their target price on Procter & Gamble from $177.00 to $179.00 and gave the company a “buy” rating in a research report on Friday, June 26th. Bank of America dropped their price target on Procter & Gamble from $170.00 to $166.00 and set a “buy” rating on the stock in a research note on Friday, July 10th. Finally, Argus downgraded Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Friday, August 7th. Fourteen equities research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $164.25.

Procter & Gamble Trading Down 1.4%

Shares of Procter & Gamble stock opened at $163.22 on Friday. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.47 and a current ratio of 0.68. The company has a market capitalization of $379.11 billion, a P/E ratio of 24.65, a PEG ratio of 3.90 and a beta of 0.39. Procter & Gamble has a 1 year low of $137.62 and a 1 year high of $167.25. The company’s fifty day moving average is $148.08 and its two-hundred day moving average is $146.99.

Procter & Gamble (NYSE:PG) last announced its earnings results on Thursday, October 22nd. The company reported $2.00 EPS for the quarter, beating analysts’ consensus estimates of $1.89 by $0.11. Procter & Gamble had a net margin of 18.44% and a return on equity of 31.36%. The business had revenue of $23.28 billion during the quarter, compared to analysts’ expectations of $22.80 billion. During the same period in the prior year, the company earned $1.99 earnings per share. The business’s revenue was up 4.0% compared to the same quarter last year. Analysts forecast that Procter & Gamble will post 6.98 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, November 16th. Investors of record on Friday, October 23rd will be given a $1.0885 dividend. This represents a $4.35 annualized dividend and a yield of 2.7%. The ex-dividend date is Friday, October 23rd. Procter & Gamble’s payout ratio is 65.71%.

Insider Activity

In other Procter & Gamble news, CAO Matthew Janzaruk sold 359 shares of the stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $145.24, for a total transaction of $52,141.16. Following the completion of the sale, the chief accounting officer directly owned 1,271 shares of the company’s stock, valued at approximately $184,600.04. This trade represents a 22.02% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Andre Schulten sold 3,914 shares of the stock in a transaction that occurred on Monday, October 5th. The stock was sold at an average price of $145.34, for a total value of $568,860.76. Following the sale, the chief financial officer directly owned 65,618 shares of the company’s stock, valued at $9,536,920.12. The trade was a 5.63% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 15,135 shares of company stock worth $2,189,970 over the last quarter. 0.23% of the stock is owned by insiders.

Key Stories Impacting Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Quarterly results exceeded expectations. Fiscal Q1 2027 adjusted earnings were $2.00 per share, above the $1.89 consensus, while revenue increased 4% year over year to $23.28 billion, surpassing estimates of roughly $22.80 billion. Procter & Gamble earnings beat as sales rise 4%
• Positive Sentiment: Underlying growth was broad and volume-driven. Organic sales rose 4%, with volume contributing 2.4 percentage points. Laundry and home-care products were among the key contributors, while favorable product mix and productivity savings supported the earnings beat. Procter & Gamble: 3 Key Takeaways for Long-Term Investors
• Positive Sentiment: Management raised its fiscal 2027 all-in sales-growth outlook. The updated forecast reflects the acquisition of Thorne and reinforces investor confidence in the company’s ability to sustain growth. The earnings beat and defensive appeal also attracted buyers as broader large-cap markets weakened, helping PG reach a new 52-week high. Procter & Gamble Boosts FY27 All-in-sales Growth Outlook
• Neutral Sentiment: Procter & Gamble’s long record of dividend increases and low-beta, defensive business model remain attractive to income-focused investors, particularly amid elevated interest rates and economic uncertainty.
• Negative Sentiment: Higher commodity, energy and transportation costs remain a major risk. Management expects these pressures to persist through fiscal 2027 and indicated they could reduce annual profit by approximately $1.4 billion, potentially limiting margin expansion despite solid sales growth. P&G flags bigger hit to annual profit from higher commodity costs

About Procter & Gamble

Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.